Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 445 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. Re-verified, no change to tracked fields
  3. Re-verified, no change to tracked fields
  4. Re-verified, no change to tracked fields
  5. Minor Eligibility criteria expanded, about 20 words
Show 45 earlier versionsHide 45 earlier versions
  1. 8 versions Re-verified since Mar 28, 2026, no change to tracked fieldsv433-v440
  2. Minor Enrollment target: 340 to 390v432
  3. 5 versions Re-verified since Nov 26, 2025, no change to tracked fieldsv427-v431
  4. Study Status, Eligibilityv426
  5. 30 versions Re-verified since Nov 16, 2024, no change to tracked fieldsv396-v425
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is intended to help develop new MRI imaging techniques for studying mood and anxiety disorders. Researchers believe that depression and anxiety disorders may cause structural and functional changes in the brain. This study will optimize the way MRI scans are collected to look at brain structure and examine how the brain behaves while subjects perform particular tasks. Healthy volunteers and individuals with major depressive disorder may be eligible for this study. Participants undergo magnetic resonance imaging (MRI) and neuropsychological testing. : Individuals will be asked to participate in an MRI study on one of several scanners. The scanner used will measure blood flow in the brain, concentrations of certain chemicals in the brain, or magnetic properties of the brain. The scan may involve They watching a screen presenting images or doing a task in which they respond to pictures or sounds. Participants may be asked to return for additional scans. The study also involves neuropsychological tests, which assess cognitive performance. Often, people with mood disorders have subtle changes in performance on these tests that allow researchers to pinpoint where brain abnormalities occur. Before the tests can be used in patients, they must be validated by using healthy subjects. These tests are presented either orally, in written form, or on a computer....
Trial Details
NCT Number NCT00397111
Lead Sponsor National Institute of Mental Health (NIMH)
Conditions
(from sponsor)
Mood Disorders, Anxiety Disorders
Related terms Anxiety Disorders, Mood Disorders
Enrollment 390 participants
Start Date
Updated on ClinicalTrials.gov